Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Phreesia (PHR) stock in plain English

Free brief · no signupStart here
PHRPublished Nov 17, 2026
Phreesia Inc
Healthcare · Health Information Services
Sells digital patient intake software, check-in pads, and payment collection systems to healthcare providers.
Assets:
PhreesiaPad hardwareDeploys custom tablets for in-office patient check-ins and payments
1,400+ employeesDistributed workforce with key operational hubs in North Carolina and Ottawa
4,000+ provider clientsIntegrations with major electronic health record systems nationwide
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

69
OPS ScoreOperating finances
Latest quote
-3.18%$11.87
$736.78M
70.3×
$508.12M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 17, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was PHR. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Phreesia (PHR) do?

Phreesia Inc (PHR) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells digital patient intake software, check-in pads, and payment collection systems to healthcare providers. It automates patient check-in and payment collection across thousands of American medical practices. It is worth $736.78M on the market and sold $508.12M over the last year.

Market cap
$736.78M
P/E ratio
70.3×
Annual sales
$508.12M
Sector
Healthcare
Industry
Health Information Services
Brief updated
Nov 17, 2026

Brands and businesses behind PHR

  • MediFind: Finds specialized doctors and clinical trials for patients, generating revenue from pharmaceutical company sponsorships.
  • Insignia Health: Licenses patient engagement assessment surveys and analytics software to healthcare organizations and insurers.

PHR’s flags, in plain English

Each flag is a number from Phreesia’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.

Still Climbing

Sales up 26.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Earnings Jumping

Profits up 627.8% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.

Growth vs Price

The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.

Priced for Perfection

Priced at 70.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about PHR

How big is Phreesia?

Phreesia’s market cap is $736.78M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $508.12M: what customers paid the company over the last year, before any costs.

What is PHR’s P/E ratio?

PHR’s P/E ratio is 70.3×. Investors pay about 70.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with PHR?

A substantial portion of total revenue relies on digital advertising budgets from pharmaceutical and life sciences companies. That is one risk on Phreesia’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Phreesia’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PHR’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card